Direxion Daily S&P Biotech Bull 3x Shares Rating → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free LABU Stock Alerts $87.51 +3.79 (+4.53%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings Direxion Daily S&P Biotech Bull 3x Shares Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LABU Aggregate RatingModerate Buy2.76Holdings in LABU have an aggregate rating of Moderate Buy based on 519 analyst ratings issued in the past year covering 41 companies (33.0% of the portfolio).LABU Aggregate Price Target$118.6435.57% UpsideHigh Prediction$160.37Average Prediction$118.64Low Prediction$78.45Holdings in LABU have an aggregate price target of $118.64 and a range of $78.45 to $160.37 covering 41 companies (33.0% of the portfolio).LABU Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy13 Buy rating(s)Moderate Buy22 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily S&P Biotech Bull 3x Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 41 LABU Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.34%ALPNAlpine Immune Sciences$64.56-0.1%2 of 5 stars2.27$50.33 -22.0%11Short Interest ↓0.97%EXASExact Sciences$58.85+0.1%4 of 5 stars2.86$97.44 65.6%14Short Interest ↑Positive News0.91%RVMDRevolution Medicines$35.96+1.8%4 of 5 stars3.10$41.20 14.6%10Positive News0.89%CYTKCytokinetics$65.34+0.8%4 of 5 stars2.87$79.33 21.4%15Insider SellingShort Interest ↑News Coverage0.87%BMRNBioMarin Pharmaceutical$80.91-1.5%5 of 5 stars2.63$107.50 32.9%19Analyst ReportOptions VolumeAnalyst RevisionNews Coverage0.86%CRNXCrinetics Pharmaceuticals$42.12-0.4%4 of 5 stars2.91$54.00 28.2%11Upcoming EarningsShort Interest ↑0.86%NTRANatera$91.66+0.4%2 of 5 stars3.00$86.40 -5.7%14Analyst DowngradeInsider Selling0.84%ROIVRoivant Sciences$11.03+1.4%4 of 5 stars2.90$16.90 53.2%10Short Interest ↑News Coverage0.84%EXELExelixis$23.70+0.7%5 of 5 stars2.60$26.29 10.9%15Upcoming EarningsShort Interest ↑Analyst RevisionNews Coverage0.83%CERECerevel Therapeutics$42.47+1.0%0 of 5 stars2.20$41.40 -2.5%10Upcoming EarningsShort Interest ↓0.83%MRNAModerna$107.97+1.7%4 of 5 stars2.25$126.49 17.1%16Upcoming EarningsInsider Selling0.82%KRYSKrystal Biotech$156.88+0.8%4 of 5 stars3.00$171.00 9.0%90.81%ALNYAlnylam Pharmaceuticals$143.31-0.3%5 of 5 stars2.59$215.88 50.6%17Upcoming EarningsShort Interest ↓News Coverage0.81%SRPTSarepta Therapeutics$128.77+1.1%4 of 5 stars2.79$156.60 21.6%14Upcoming EarningsAnalyst RevisionNews Coverage0.80%AMGNAmgen$269.98+0.2%5 of 5 stars2.53$297.40 10.2%19Upcoming Earnings0.80%INSMInsmed$24.80-0.5%4 of 5 stars3.00$44.92 81.1%12Analyst ReportNews Coverage0.79%DYNDyne Therapeutics$24.73+4.4%4 of 5 stars3.14$37.43 51.3%7Short Interest ↑News Coverage0.79%NBIXNeurocrine Biosciences$135.99-1.3%5 of 5 stars2.74$142.38 4.7%23Upcoming EarningsAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage0.78%UTHRUnited Therapeutics$233.85-0.9%5 of 5 stars2.89$294.25 25.8%9Upcoming EarningsInsider SellingNews Coverage0.78%GERNGeron$3.79+6.5%3 of 5 stars3.00$5.33 40.7%3Upcoming EarningsShort Interest ↑News Coverage0.78%VRTXVertex Pharmaceuticals$397.48-0.1%4 of 5 stars2.48$429.45 8.0%230.78%VKTXViking Therapeutics$74.31+7.9%5 of 5 stars3.00$112.25 51.1%10Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage0.78%RYTMRhythm Pharmaceuticals$38.28+0.3%2 of 5 stars3.00$47.20 23.3%5Analyst ReportNews Coverage0.77%BPMCBlueprint Medicines$93.00+2.5%1 of 5 stars2.50$91.57 -1.5%14Upcoming EarningsAnalyst ReportNews CoverageGap Up0.77%IONSIonis Pharmaceuticals$41.59-0.6%4 of 5 stars2.69$56.08 34.8%13Upcoming Earnings0.76%REGNRegeneron Pharmaceuticals$883.20-0.8%5 of 5 stars2.70$977.77 10.7%20Upcoming EarningsAnalyst ReportAnalyst RevisionNews Coverage0.76%RAREUltragenyx Pharmaceutical$44.24+0.9%4 of 5 stars2.92$88.08 99.1%12Upcoming EarningsAnalyst Report0.76%MDGLMadrigal Pharmaceuticals$193.33-0.5%5 of 5 stars2.73$356.73 84.5%110.76%IMVTImmunovant$27.17-2.1%3 of 5 stars3.00$48.00 76.7%17Insider SellingShort Interest ↓Analyst RevisionNews Coverage0.75%VERAVera Therapeutics$39.65+2.5%1 of 5 stars3.00$32.29 -18.6%80.75%BHVNBiohaven$38.97+1.1%4 of 5 stars3.00$52.13 33.8%8Analyst ReportInsider BuyingAnalyst RevisionNews Coverage0.75%BBIOBridgeBio Pharma$24.88+2.3%4 of 5 stars2.80$47.82 92.2%10Upcoming EarningsShort Interest ↑News Coverage0.75%ARQTArcutis Biotherapeutics$8.47-1.4%2 of 5 stars2.75$26.56 213.5%8Options VolumeNews Coverage0.75%IDYAIDEAYA Biosciences$39.94+3.4%3 of 5 stars3.00$46.60 16.7%120.75%HALOHalozyme Therapeutics$38.57+0.3%5 of 5 stars2.86$53.29 38.2%7Analyst RevisionNews Coverage0.74%GILDGilead Sciences$65.42+0.2%5 of 5 stars2.35$83.87 28.2%17Earnings ReportDividend AnnouncementAnalyst UpgradeOptions VolumeAnalyst RevisionNews Coverage0.74%ABBVAbbVie$159.62-4.6%5 of 5 stars2.77$176.08 10.3%13Earnings ReportNews CoverageHigh Trading Volume0.73%VCELVericel$46.05+1.3%0 of 5 stars3.00$46.40 0.8%6News Coverage0.73%INCYIncyte$51.68+1.0%5 of 5 stars2.44$75.50 46.1%16Upcoming EarningsAnalyst ReportAnalyst Revision0.73%DVAXDynavax Technologies$11.21+0.4%4 of 5 stars2.75$25.00 123.0%4Analyst Downgrade0.72%BIIBBiogen$208.90+3.2%5 of 5 stars2.67$293.88 40.7%27Earnings ReportAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage This page (NYSEARCA:LABU) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
